Top-News
Gesundheitswesen: Ausstattung u. Produkte USA

ResMed News

Aktie
WKN:  895878 ISIN:  US7611521078 US-Symbol:  RMD
201,15 €
-0,025 €
-0,01%
07:48:47 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
146,07 Mio.
Marktkapitalisierung *
29,37 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
S&P 500
IR-Website
zur Website
*Stand: 31.07.2023
Weiter abwärts? Short handeln - Jetzt mit Hebel 7,12: ME5SUH

ResMed News

02.05.23 - GlobeNewswire
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
Rider and Haake, both internal promotions, joined ResMed’s executive team on May 1 Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring ...
28.04.23 - ARIVA.DE Redaktion
S&P 500 zieht etwas an: 0,65 Punkte gutgemacht
Für den S&P 500-Index verlief der bisherige Aktienhandel heute positiv. Der Index steigt um 0,65 Prozent auf 4.162 Punkte.
30.03.23 - GlobeNewswire
ResMed Chief Administrative Officer and Global General Counsel to Retire
ResMed to conduct an internal search for a successor general counsel Amy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive ...
13.03.23 - GlobeNewswire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleep Women and older ...
26.01.23 - GlobeNewswire
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael ...
22.11.22 - GlobeNewswire
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
-  Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market
04.09.22 - GlobeNewswire
Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
New prevalence figure 22–126% higher than previous estimates Prevalence expected to reach 592 million by 2050 Researchers urge global action on smoking cessation and air ...
11.08.22 - PLX
ResMed Q4 Revenue Below Expectations
(PLX AI) – ResMed Q4 revenue USD 914.7 million vs. estimate USD 921 million. • Q4 gross margin 57.1% • Q4 adjusted gross margin 57.8% • Q4 adjusted EPS USD 1.49 • Q4 EPS ...
28.06.22 - GlobeNewswire
ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care
Blaise is a medtech industry thought leader with over 25 years’ experience A board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech ...
14.06.22 - Der Aktionär
AKTIONÄR‑Tipp ResMed schlägt in Deutschland zu – die Details
14.06.22 - PLX
Resmed to Buy Medifox Dan for $1 Billion
(PLX AI) – Resmed to Acquire MEDIFOX DAN, a German Leader in Out-​of-Hospital Software Solutions • Resmed says purchase price is approximately $1 billion • Target will integrate ...
14.06.22 - GlobeNewswire
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
Acquisition creates a global leader in out-​of-hospital software solutions Accelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS ...
25.05.22 - GlobeNewswire
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the ...
18.05.22 - GlobeNewswire
Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study
2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 years Health benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, ...
05.05.22 - GlobeNewswire
ResMed Announces Leadership Change
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ...
28.04.22 - PLX
Resmed Q3 Earnings Below Expectations on Revenue, EPS
(PLX AI) – Resmed Q3 revenue USD 864.5 million vs. estimate USD 897 million • Q3 gross margin 56.8% • Q3 adjusted EPS USD 1.32 vs. estimate USD 1.42 • Q3 EPS USD 1.22
28.04.22 - GlobeNewswire
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
Year-​over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at  ...
27.04.22 - GlobeNewswire
ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie ...
07.04.22 - GlobeNewswire
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of ...
23.03.22 - ARIVA.DE Redaktion
Börsen USA: S&P 500 tendiert zur Stunde leichter
Für den S&P 500-Index brachte der bisherige Aktienhandel heute leichte Verluste. Der Index sinkt leicht um 0,98 Prozent.

Newssuche

Videos

17.05.24 -6,64%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »